These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 19717730)

  • 1. Genetic inhibition of calcineurin induces diastolic dysfunction in mice with chronic pressure overload.
    Gelpi RJ; Gao S; Zhai P; Yan L; Hong C; Danridge LM; Ge H; Maejima Y; Donato M; Yokota M; Molkentin JD; Vatner DE; Vatner SF; Sadoshima J
    Am J Physiol Heart Circ Physiol; 2009 Nov; 297(5):H1814-9. PubMed ID: 19717730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Maturation-dependent differences in regulation of sarcoplasmic reticulum Ca(2+) ATPase in sheep myocardium in response to pressure overload: a possible mechanism for maturation-dependent systolic and diastolic dysfunction.
    Aoyagi T; Fujii AM; Flanagan MF; Arnold L; Mirsky I; Izumo S
    Pediatr Res; 2001 Aug; 50(2):246-53. PubMed ID: 11477211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. O-GlcNAc Transferase Promotes Compensated Cardiac Function and Protein Kinase A O-GlcNAcylation During Early and Established Pathological Hypertrophy From Pressure Overload.
    Zhu WZ; El-Nachef D; Yang X; Ledee D; Olson AK
    J Am Heart Assoc; 2019 Jun; 8(11):e011260. PubMed ID: 31131693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estrogen attenuates left ventricular and cardiomyocyte hypertrophy by an estrogen receptor-dependent pathway that increases calcineurin degradation.
    Donaldson C; Eder S; Baker C; Aronovitz MJ; Weiss AD; Hall-Porter M; Wang F; Ackerman A; Karas RH; Molkentin JD; Patten RD
    Circ Res; 2009 Jan; 104(2):265-75, 11p following 275. PubMed ID: 19074476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased passive stiffness promotes diastolic dysfunction despite improved Ca2+ handling during left ventricular concentric hypertrophy.
    Røe ÅT; Aronsen JM; Skårdal K; Hamdani N; Linke WA; Danielsen HE; Sejersted OM; Sjaastad I; Louch WE
    Cardiovasc Res; 2017 Aug; 113(10):1161-1172. PubMed ID: 28472418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of Protein Kinase Novel 1 (PKN1) is associated with mild systolic and diastolic contractile dysfunction, increased phospholamban Thr17 phosphorylation, and exacerbated ischaemia-reperfusion injury.
    Francois AA; Obasanjo-Blackshire K; Clark JE; Boguslavskyi A; Holt MR; Parker PJ; Marber MS; Heads RJ
    Cardiovasc Res; 2018 Jan; 114(1):138-157. PubMed ID: 29045568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impaired contractile function and calcium handling in hearts of cardiac-specific calcineurin b1-deficient mice.
    Schaeffer PJ; Desantiago J; Yang J; Flagg TP; Kovacs A; Weinheimer CJ; Courtois M; Leone TC; Nichols CG; Bers DM; Kelly DP
    Am J Physiol Heart Circ Physiol; 2009 Oct; 297(4):H1263-73. PubMed ID: 19700627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early calcium handling imbalance in pressure overload-induced heart failure with nearly normal left ventricular ejection fraction.
    Rouhana S; Farah C; Roy J; Finan A; Rodrigues de Araujo G; Bideaux P; Scheuermann V; Saliba Y; Reboul C; Cazorla O; Aimond F; Richard S; Thireau J; Fares N
    Biochim Biophys Acta Mol Basis Dis; 2019 Jan; 1865(1):230-242. PubMed ID: 30463691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concentric left ventricular remodeling in endothelial nitric oxide synthase knockout mice by chronic pressure overload.
    Ruetten H; Dimmeler S; Gehring D; Ihling C; Zeiher AM
    Cardiovasc Res; 2005 Jun; 66(3):444-53. PubMed ID: 15914109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FKBP12.6 mice display temporal gender differences in cardiac Ca(2+)-signalling phenotype upon chronic pressure overload.
    Prévilon M; Pezet M; Semprez F; Mercadier JJ; Rouet-Benzineb P
    Can J Physiol Pharmacol; 2011 Nov; 89(11):769-82. PubMed ID: 22007848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term levosimendan treatment improves systolic function and myocardial relaxation in mice with cardiomyocyte-specific disruption of the Serca2 gene.
    Hillestad V; Kramer F; Golz S; Knorr A; Andersson KB; Christensen G
    J Appl Physiol (1985); 2013 Nov; 115(10):1572-80. PubMed ID: 24072410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Type 1 diabetic cardiomyopathy in the Akita (Ins2WT/C96Y) mouse model is characterized by lipotoxicity and diastolic dysfunction with preserved systolic function.
    Basu R; Oudit GY; Wang X; Zhang L; Ussher JR; Lopaschuk GD; Kassiri Z
    Am J Physiol Heart Circ Physiol; 2009 Dec; 297(6):H2096-108. PubMed ID: 19801494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ubiquitin ligase
    Snyder LB; Lai Y; Doviak H; Freeburg LA; Laney VK; Moore A; Zellars KN; Matesic LE; Spinale FG
    Am J Physiol Heart Circ Physiol; 2021 Nov; 321(5):H976-H984. PubMed ID: 34559578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activated expression of cardiac adenylyl cyclase 6 reduces dilation and dysfunction of the pressure-overloaded heart.
    Sugano Y; Lai NC; Gao MH; Firth AL; Yuan JX; Lew WY; Hammond HK
    Biochem Biophys Res Commun; 2011 Feb; 405(3):349-55. PubMed ID: 21195051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induced overexpression of phospholemman S68E mutant improves cardiac contractility and mortality after ischemia-reperfusion.
    Wang J; Song J; Gao E; Zhang XQ; Gu T; Yu D; Koch WJ; Feldman AM; Cheung JY
    Am J Physiol Heart Circ Physiol; 2014 Apr; 306(7):H1066-77. PubMed ID: 24486513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Curcumin inhibits cardiac hypertrophy and improves cardiovascular function via enhanced Na
    Bai XJ; Hao JT; Wang J; Zhang WF; Yan CP; Zhao JH; Zhao ZQ
    Pharmacol Rep; 2018 Feb; 70(1):60-68. PubMed ID: 29331788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concomitant systolic and diastolic alterations during chronic hypertension in pig.
    Jozwiak M; Meli AC; Melka J; Rienzo M; d'Anglemont de Tassigny A; Saint N; Bizé A; Sambin L; Scheuermann V; Cazorla O; Hittinger L; Berdeaux A; Su JB; Bouhemad B; Lacampagne A; Ghaleh B
    J Mol Cell Cardiol; 2019 Jun; 131():155-163. PubMed ID: 31051181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of AKAP150 promotes pathological remodelling and heart failure propensity by disrupting calcium cycling and contractile reserve.
    Li L; Li J; Drum BM; Chen Y; Yin H; Guo X; Luckey SW; Gilbert ML; McKnight GS; Scott JD; Santana LF; Liu Q
    Cardiovasc Res; 2017 Feb; 113(2):147-159. PubMed ID: 27856611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rescue of Ca2+ overload-induced left ventricular dysfunction by targeted ablation of phospholamban.
    Tsuji T; Del Monte F; Yoshikawa Y; Abe T; Shimizu J; Nakajima-Takenaka C; Taniguchi S; Hajjar RJ; Takaki M
    Am J Physiol Heart Circ Physiol; 2009 Feb; 296(2):H310-7. PubMed ID: 19074672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A gene therapeutic approach to inhibit calcium and integrin binding protein 1 ameliorates maladaptive remodelling in pressure overload.
    Grund A; Szaroszyk M; Döppner JK; Malek Mohammadi M; Kattih B; Korf-Klingebiel M; Gigina A; Scherr M; Kensah G; Jara-Avaca M; Gruh I; Martin U; Wollert KC; Gohla A; Katus HA; Müller OJ; Bauersachs J; Heineke J
    Cardiovasc Res; 2019 Jan; 115(1):71-82. PubMed ID: 29931050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.